Search all trials

Find therapies in clinical trials near you – page 31

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drugNo placebo

Study on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Type IIa hyperlipidaemia+1

Not recruiting

InvestigationalNo placebo

Study of Bempedoic Acid for Children Aged 6-17 with Familial Hypercholesterolemia

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Bempedoic Acid

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Registered drug

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Ovarian cancer recurrent

Not recruiting

InvestigationalNo placebo

Study of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Avutometinib

Contact Research Centre

Cardiomyopathy+1

Not recruiting

Investigational

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Autologous Bone Marrow-Derived Adult Mononuclear Cells, Not Expanded

Contact Research Centre

Pain

Not recruiting

Registered drug

Study on Pain Relief After Dental Surgery Using Ibuprofen Arginine and Tramadol Hydrochloride for Patients with Moderate to Severe Pain

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Ibuprofen

Contact Research Centre

Endometrial cancer recurrent

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Capivasertib and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer After Standard Treatment Progression

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cabazitaxel

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Safety and efficacy study of RTX001 autologous macrophage therapy in patients with decompensated liver cirrhosis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Ovarian low malignant potential tumour

Not recruiting

InvestigationalNo placebo

Study of catequentinib (AL3818) combined with platinum chemotherapy for patients with recurrent or metastatic ovarian, fallopian tube, or primary peritoneal cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Catequentinib Dihydrochloride

Contact Research Centre

Find therapies in clinical trials near you – page 31

564 trials match your criteria

HER2 positive breast cancer

Study on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer

Non-small cell lung cancer+2

Study on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer

Type IIa hyperlipidaemia+1

Study of Bempedoic Acid for Children Aged 6-17 with Familial Hypercholesterolemia

Endocrine ophthalmopathy

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Ovarian cancer recurrent

Study of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer

Cardiomyopathy+1

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Pain

Study on Pain Relief After Dental Surgery Using Ibuprofen Arginine and Tramadol Hydrochloride for Patients with Moderate to Severe Pain

Endometrial cancer recurrent

Study on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain

Breast cancer

Study on Capivasertib and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer After Standard Treatment Progression

Prostate cancer

A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

Hepatic cirrhosis

Safety and efficacy study of RTX001 autologous macrophage therapy in patients with decompensated liver cirrhosis

Ovarian low malignant potential tumour

Study of catequentinib (AL3818) combined with platinum chemotherapy for patients with recurrent or metastatic ovarian, fallopian tube, or primary peritoneal cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.